Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other


JORDEN DAVID EMERSON Create: Alert

All | News | Filings
Date FiledTypeDescription
11/14/2022 4 JORDEN DAVID EMERSON (CEO/CFO) has filed a Form 4 on Nuo Therapeutics, Inc.
Txns: Sold 30,000 shares @ $1.5, valued at $45k
Sold 27,000 shares @ $1.5, valued at $40.5k
Sold 20,000 shares @ $1.5, valued at $30k
Sold 13,500 shares @ $1.5, valued at $20.3k
Sold 10,000 shares @ $1.5, valued at $15k
Sold 7,000 shares @ $1.5, valued at $10.5k
Sold 5,000 shares @ $1.5, valued at $7.5k
07/05/2022 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
05/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/26/2022 4 JORDEN DAVID EMERSON (CEO/CFO) has filed a Form 4 on Nuo Therapeutics, Inc.
Txns: Granted 66,672 options to buy @ $0.5, valued at $33.3k
Granted 125,000 options to buy @ $0.75, valued at $93.8k
04/26/2022 5 JORDEN DAVID EMERSON (CEO/CFO) has filed a Form 5 on Nuo Therapeutics, Inc.
04/26/2022 5 JORDEN DAVID EMERSON (CEO/CFO) has filed a Form 5 on Nuo Therapeutics, Inc.
04/26/2022 5 JORDEN DAVID EMERSON (CEO/CFO) has filed a Form 5 on Nuo Therapeutics, Inc.
01/03/2019 4 JORDEN DAVID EMERSON (CEO, CFO) has filed a Form 4 on Nuo Therapeutics, Inc.
Txns: Granted 125,000 options to buy @ $0.4, valued at $50k
08/13/2018 4 JORDEN DAVID EMERSON (CEO, CFO) has filed a Form 4 on Nuo Therapeutics, Inc.
Txns: Granted 192,710 options to buy @ $0.4, valued at $77.1k
08/14/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2017 4 JORDEN DAVID EMERSON (Acting CFO) has filed a Form 4 on PLx Pharma Inc.
Txns: Bought 32,727 shares @ $6.875, valued at $225k
Bought 32,727 warrants @ $7.5, valued at $245.5k
04/20/2017 4 JORDEN DAVID EMERSON (Acting CFO) has filed a Form 4 on PLx Pharma Inc.
04/20/2017 3 JORDEN DAVID EMERSON (Acting CFO) has filed a Form 3 on PLx Pharma Inc.
01/11/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
07/15/2015 4 JORDEN DAVID EMERSON (Acting CFO) has filed a Form 4 on Nuo Therapeutics, Inc.
Txns: Granted 250,000 options to buy @ $0.21, valued at $52.5k
09/26/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
07/02/2013 4 JORDEN DAVID EMERSON (Director) has filed a Form 4 on Opexa Therapeutics, Inc.
Txns: Granted 4,450 shares @ $1.54, valued at $6.9k
05/21/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
05/01/2013 4 JORDEN DAVID EMERSON (Director) has filed a Form 4 on Opexa Therapeutics, Inc.
Txns: Granted 5,000 options to buy @ $1.75, valued at $8.8k
Granted 17,143 options to buy @ $1.75, valued at $30k
02/27/2013 4 JORDEN DAVID EMERSON (Acting CFO) has filed a Form 4 on Opexa Therapeutics, Inc.
Txns: Disposed/sold convertible notes @ $1.3, valued at $0
02/27/2013 4 JORDEN DAVID EMERSON (Director) has filed a Form 4 on CYTOMEDIX INC
Txns: Bought 20,600 shares @ $0.52, valued at $10.7k
Bought 4,400 shares @ $0.53, valued at $2.3k
Bought 20,600 shares @ $0.52, valued at $10.7k
Bought 4,400 shares @ $0.53, valued at $2.3k
02/22/2013 4 JORDEN DAVID EMERSON (Director) has filed a Form 4 on CYTOMEDIX INC
Txns: Bought 30,000 shares @ $0.53, valued at $15.9k
Bought 20,000 shares @ $0.53, valued at $10.6k
01/24/2013 4 JORDEN DAVID EMERSON (Acting CFO) has filed a Form 4 on Opexa Therapeutics, Inc.
Txns: Granted 4,595 shares @ $1.33, valued at $6.1k
Granted convertible notes @ $1.3, valued at $0
Granted 37,500 warrants @ $1.24, valued at $46.5k
09/14/2012 4 JORDEN DAVID EMERSON (Director) has filed a Form 4 on CYTOMEDIX INC
Txns: Bought 25,000 shares @ $0.89, valued at $22.3k
09/12/2012 4 JORDEN DAVID EMERSON (Director) has filed a Form 4 on CYTOMEDIX INC
Txns: Bought 8,333 shares @ $0.95, valued at $7.9k
08/31/2012 4 JORDEN DAVID EMERSON (Director) has filed a Form 4 on CYTOMEDIX INC
Txns: Exercised (in-or-at-the-money) 16,667 shares @ $1, valued at $16.7k
Exercised (in-or-at-the-money) 16,667 warrants @ $0
08/16/2012 4 JORDEN DAVID EMERSON (Acting CFO) has filed a Form 4 on Opexa Therapeutics, Inc.
Txns: Granted 75,000 options to buy @ $0.51, valued at $38.3k
07/27/2012 4 JORDEN DAVID EMERSON (Director) has filed a Form 4 on Opexa Therapeutics, Inc.
Txns: Granted options to buy @ $100, valued at $0
Granted 107,813 warrants @ $1.25, valued at $134.8k
03/05/2012 4 JORDEN DAVID EMERSON (Director) has filed a Form 4 on Opexa Therapeutics, Inc.
Txns: Granted 10,000 options to buy @ $0.94, valued at $9.4k
Granted 20,600 options to buy @ $0.94, valued at $19.4k
01/30/2012 4 JORDEN DAVID EMERSON (10% Owner) has filed a Form 4 on CYTOMEDIX INC
Txns: Acquired 1,854 shares @ $0
12/06/2011 4 JORDEN DAVID EMERSON (10% Owner) has filed a Form 4 on CYTOMEDIX INC
Txns: Granted 50,000 options to buy @ $0.8, valued at $40k
10/17/2011 4 JORDEN DAVID EMERSON (10% Owner) has filed a Form 4 on CYTOMEDIX INC
Txns: Acquired 3,793 shares @ $0
07/18/2011 4 JORDEN DAVID EMERSON (10% Owner) has filed a Form 4 on CYTOMEDIX INC
Txns: Acquired 5,000 shares @ $0
06/07/2011 4 Form 4 - Statement of changes in beneficial ownership of securities
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy